Cargando…
Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment
INTRODUCTION: As research continues, new drugs will no doubt be added to the current pool of treatments for moderate-to-severe atopic dermatitis (AD). This raises the need for studies to determine prescriber preferences for different pharmacological options and the factors that influence their choic...
Autores principales: | Carrascosa Carrillo, José Manuel, Baselga Torres, Eulalia, Gilaberte Calzada, Yolanda, Jurgens Martínez, Yanina Nancy, Roustan Gullón, Gastón, Yanguas Bayona, Juan Ignacio, Gómez Castro, Susana, Ferrario, Maria Giovanna, Rebollo Laserna, Francisco José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022060/ https://www.ncbi.nlm.nih.gov/pubmed/35445962 http://dx.doi.org/10.1007/s13555-022-00723-z |
Ejemplares similares
-
Clinical remission of disseminated molluscum contagiosum infection in a patient with atopic dermatitis treated with dupilumab()
por: Elosua-González, Marta, et al.
Publicado: (2022) -
Safety Profile and Tolerability of Topical Phosphodiesterase 4 Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
por: Martín-Santiago, Ana, et al.
Publicado: (2022) -
Patient Journey in Atopic Dermatitis: The Real-World Scenario
por: Carrascosa, Jose Manuel, et al.
Publicado: (2021) -
Colonization With Staphylococcus aureus in Atopic Dermatitis Patients: Attempts to Reveal the Unknown
por: Ogonowska, Patrycja, et al.
Publicado: (2021) -
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
por: WOLLENBERG, Andreas, et al.
Publicado: (2022)